Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Am J Hematol
3 Ann Hematol
4 Blood
2 Bone Marrow Transplant
1 Clin Infect Dis
1 Eur J Haematol
1 Int J Hematol
7 J Pediatr Hematol Oncol
1 J Virol
4 Leuk Lymphoma
2 Leuk Res
6 Leukemia
1 N Engl J Med
1 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hematol

  1. MOULIN C, Guillemin F, Remen T, Bouclet F, et al
    Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: a study of the French Innovative Leukemia Organization.
    Am J Hematol. 2021 May 17. doi: 10.1002/ajh.26239.

    Ann Hematol

  2. TANG KHK, Ip AHW, Kwong YL
    Clonal derivation of sequential seminoma and acute megakaryoblastic leukaemia.
    Ann Hematol. 2021;100:1337-1339.

  3. HORIUCHI M, Yoshida M, Yamasaki K, Sakagami R, et al
    Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion.
    Ann Hematol. 2021;100:1329-1331.

  4. BERNARDI S, Zanaglio C, Farina M, Polverelli N, et al
    dsDNA from extracellular vesicles (EVs) in adult AML.
    Ann Hematol. 2021;100:1355-1356.


  5. BORELLA G, Da Ros A, Borile G, Porcu E, et al
    Targeting mesenchymal stromal cells plasticity to reroute acute myeloid leukemia course.
    Blood. 2021 May 19. pii: 475978. doi: 10.1182/blood.2020009845.
    PubMed         Abstract available

  6. VAN DER KOUWE E, Heller G, Czibere A, Pulikkan JA, et al
    Core binding factor leukemia hijacks T-cell prone PU.1 antisense promoter.
    Blood. 2021 May 19. pii: 475975. doi: 10.1182/blood.2020008971.
    PubMed         Abstract available

  7. KOHLHAAS V, Blakemore SJ, Al-Maarri M, Nickel N, et al
    Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
    Blood. 2021;137:646-660.
    PubMed         Abstract available

  8. FALINI B, Brunetti L, Martelli MP
    How I diagnose and treat NPM1-mutated AML.
    Blood. 2021;137:589-599.
    PubMed         Abstract available

    Bone Marrow Transplant

  9. BEAUVERD Y, Morin S, Stephan C, De Ramon Ortiz C, et al
    The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
    Bone Marrow Transplant. 2021 May 18. pii: 10.1038/s41409-021-01334.

  10. PERCIVAL ME, Wang HL, Zhang MJ, Saber W, et al
    Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2021 May 20. pii: 10.1038/s41409-021-01353.

    Clin Infect Dis

    Evidence in Microbiome Science: Standards for the Field (and Laboratory).
    Clin Infect Dis. 2021;72:1514-1516.

    Eur J Haematol

  12. MACHHERNDL-SPANDL S, Jager E, Barna A, Gurbisz M, et al
    Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukemia.
    Eur J Haematol. 2021 May 16. doi: 10.1111/ejh.13647.
    PubMed         Abstract available

    Int J Hematol

  13. ARAKAWA Y, Masutani S, Oshima K, Mitani Y, et al
    Asian population may have a lower incidence of hip osteonecrosis in childhood acute lymphoblastic leukemia.
    Int J Hematol. 2021 May 18. pii: 10.1007/s12185-021-03163.
    PubMed         Abstract available

    J Pediatr Hematol Oncol

  14. GRUHN B, Brodt G, Ernst J
    Extended Treatment With Mesenchymal Stromal Cells-Frankfurt am Main in a Pediatric Patient With Steroid-refractory Acute Gastrointestinal Graft-Versus-Host Disease: Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2021;43:e419-e425.
    PubMed         Abstract available

  15. FERTAL SA, Bradeen HA, Friesen E, Heath JL, et al
    Time Course and Management of Protracted Anaphylaxis Due to PEG-Asparaginase.
    J Pediatr Hematol Oncol. 2021;43:e385-e387.
    PubMed         Abstract available

  16. FUJINO H, Nii S, Sumimoto S
    Mediastinal Gamma-Delta T-Cell Lymphoblastic Lymphoma Successfully Treated With Chemotherapy Alone.
    J Pediatr Hematol Oncol. 2021;43:117-118.

  17. CASTELLANOS MI, Dongarwar D, Wanser R, Caceres I, et al
    In-hospital Mortality and Racial Disparity in Children and Adolescents With Acute Myeloid Leukemia: A Population-based Study.
    J Pediatr Hematol Oncol. 2021 May 18. pii: 00043426-900000000-96873.
    PubMed         Abstract available

  18. NGUYEN M, Naeem F, Razzaqi F, Vijayan V, et al
    Invasive Trichosporonosis in a 2-Year-Old With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2021 May 18. pii: 00043426-900000000-96874.

  19. EGAN-SHERRY D, Bhuta R, Cole PD, Gennarini LM, et al
    Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term Outcome.
    J Pediatr Hematol Oncol. 2021 May 18. pii: 00043426-900000000-96877.
    PubMed         Abstract available

  20. UCHIDA E, Kurata T, Komori K, Kobayashi J, et al
    Sequential Therapy of Inotuzumab Ozogamicin and Blinatumomab as a Bridge-to Hematopoietic Stem Cell Transplantation in a Pediatric Patient With Primary Refractory Acute Lymphoblastic Leukemia: A Case Report.
    J Pediatr Hematol Oncol. 2021 May 18. pii: 00043426-900000000-96888.
    PubMed         Abstract available

    J Virol

  21. WANG GZ, Goff SP
    Moloney murine leukemia virus p12 is required for histone loading onto retroviral DNAs.
    J Virol. 2021 May 19. pii: JVI.00495-21. doi: 10.1128/JVI.00495.
    PubMed         Abstract available

    Leuk Lymphoma

  22. TIGLIOGLU M, Albayrak M, Dogan S, Yilmaz F, et al
    Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis.
    Leuk Lymphoma. 2021 May 20:1-7. doi: 10.1080/10428194.2021.1929962.
    PubMed         Abstract available

  23. HANDL S, von Heydebrand F, Voelkl S, Oostendorp RAJ, et al
    Immune modulatory effects of Idelalisib in stromal cells of chronic lymphocytic leukemia.
    Leuk Lymphoma. 2021 May 17:1-11. doi: 10.1080/10428194.2021.1927019.
    PubMed         Abstract available

  24. LIANG D, Wei C, Zhang X, Yang J, et al
    Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation.
    Leuk Lymphoma. 2021 May 17:1-5. doi: 10.1080/10428194.2021.1919665.

  25. MARQUES-PIUBELLI ML, Schlette EJ, Khoury JD, Furqan F, et al
    Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax.
    Leuk Lymphoma. 2021;62:1129-1135.
    PubMed         Abstract available

    Leuk Res

  26. SPEROTTO A, Gottardi M, Candoni A, Toffoletti E, et al
    WT1 - Gene expression driven pre-emptive treatment with decitabine for molecular relapse of acute myeloid leukemia after allogeneic stem cell transplant.
    Leuk Res. 2021;108:106587.

  27. FIEGLE E, Crysandt M, Bouillon AS, Silling G, et al
    Successful allogeneic stem cell transplantation of a patient with Werner syndrome and acute myeloid leukemia.
    Leuk Res. 2021 May 5:106609. doi: 10.1016/j.leukres.2021.106609.


  28. BRECCIA M, Pregno P, Castagnetti F, Bonifacio M, et al
    Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study.
    Leukemia. 2021 May 17. pii: 10.1038/s41375-021-01292.

  29. CARRATT SA, Braun TP, Coblentz C, Schonrock Z, et al
    Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.
    Leukemia. 2021 May 17. pii: 10.1038/s41375-021-01278.
    PubMed         Abstract available

  30. DOURTHE ME, Rabian F, Yakouben K, Chevillon F, et al
    Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia.
    Leukemia. 2021 May 17. pii: 10.1038/s41375-021-01281.
    PubMed         Abstract available

  31. VAN DER WERF I, Wojtuszkiewicz A, Yao H, Sciarrillo R, et al
    SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia.
    Leukemia. 2021 May 17. pii: 10.1038/s41375-021-01273.

  32. VAN DER ZWET JCG, Buijs-Gladdines JGCAM, Cordo' V, Debets DO, et al
    MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance.
    Leukemia. 2021 May 18. pii: 10.1038/s41375-021-01291.
    PubMed         Abstract available

  33. JAIN N, Thompson P, Burger J, Ferrajoli A, et al
    Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations.
    Leukemia. 2021 May 18. pii: 10.1038/s41375-021-01280.
    PubMed         Abstract available

    N Engl J Med

  34. MEJIA BURITICA L, Karduss Urueta AJ
    Pulmonary Mucormycosis.
    N Engl J Med. 2021;384:e69.

    Oncol Rep

  35. YAO J, Luo Y, Zeng C, He H, et al
    UHRF1 regulates the transcriptional repressor HBP1 through MIF in T acute lymphoblastic leukemia.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.